However these compounds were designed as competitive antagonists to be active in the brain of patients having low
concentration of adenosine whereas high levels adenosine are produced by ectonucleotidases, especially CD73 and CD39 that are overexpressed in the tumor microenvironment.
They found that
the concentration of adenosine rises steadily during periods of alertness, when the brain uses the most energy, and drops during naps or deep sleep.
iTeos Therapeutics has developed a novel and potent best - in - class A2A blocker that has been specifically optimized for immuno - oncology indications to retain a high potency in the adenosine - rich environment found in tumors and to restore cytokine production even in the presence of high
concentrations of adenosine.
Not exact matches
Adenosine 3», 5» - monophosphate at a
concentration of 5 x 10 - 7 mole per liter causes a 400 percent increase in the rate
of phosphorylation
of histone catalyzed by a partially purified enzyme preparation from rabbit brain.
The researchers reported a 24-fold increase in
adenosine concentration in the blood
of the animals after acupuncture, which corresponded to a two - thirds reduction in discomfort, as revealed by how quickly they recoiled from heat and touch.
The difference in the
concentration of protons across these two environments enabled protons to flow into the cell, driving the production
of a molecule called
adenosine triphosphate (ATP) which powered the growth
of cells, just as it does today.
The company showed how they first defined A2A as the receptor required for mediating the effect
of adenosine on immune cells within the tumor microenvironment and reported the characterization
of a novel immuno - oncology - dedicated
adenosine receptor 2A antagonist that functions in the high
adenosine concentration found in tumors.
EOS100850 promotes anti-tumor efficacy in mouse tumor models in combination with several immune - checkpoint inhibitors, retains high potency in the presence
of elevated intra-tumoral
adenosine concentrations, and is non-brain penetrant.
«These preclinical results show the potential
of our compound to target the inhibition
of the A2A receptor in the challenging context
of tumor - like
adenosine concentrations.
EOS100850 potently inhibits A2A receptor in T lymphocytes, at single digit nanomolar
concentrations, independently
of adenosine concentrations
This study investigated the influence
of chronically administered curcumin on normal ageing - related parameters: lipid peroxidation, lipofuscin
concentration and intraneuronal lipofuscin accumulation, activities
of the enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx), and Na (+), K (+), -
adenosine triphosphatase (Na (+), K (+), - ATPase) in different brain regions (cerebral cortex, hippocampus, cerebellum and medulla)
of 6 - and 24 - month - old rats.